bluuebunny/crossref_metadata_2025 huggingface dataset:
Related Article from Do We Need a Different Set of Response Assessment Criteria for Tumor Immunotherapy?
Authors: Ribas Antoni , Chmielowski Bartosz , Glaspy John A.
Published: April 2023

Related Article from Do We Need a Different Set of Response Assessment Criteria for Tumor Immunotherapy?
Supplementary Data from Lung Squamous Cell Carcinoma mRNA Expression Subtypes Are Reproducible, Clinically Important, and Correspond to Normal Cell Types
Authors: Wilkerson Matthew D. , Yin Xiaoying , Hoadley Katherine A. , Liu Yufeng , Hayward Michele C. , Cabanski Christopher R. , Muldrew Kenneth , Miller C. Ryan , Randell Scott H. , Socinski Mark A. , Parsons Alden M. , Funkhouser William K. , Lee Carrie B. , Roberts Patrick J. , Thorne Leigh , Bernard Philip S. , Perou Charles M. , Hayes D. Neil
Published: April 2023

Supplementary Figures S1-S8, Supplementary Materials and Methods, and Supplementary Tables S1-S2.
Supplementary Data from CXCR2 Promotes Ovarian Cancer Growth through Dysregulated Cell Cycle, Diminished Apoptosis, and Enhanced Angiogenesis
Authors: Yang Gong , Rosen Daniel G. , Liu Guangzhi , Yang Fan , Guo Xiaoqing , Xiao Xue , Xue Fengxia , Mercado-Uribe Imelda , Huang Jiaoti , Lin Sue-Hwa , Mills Gordon B. , Liu Jinsong
Published: April 2023

Supplementary Data from CXCR2 Promotes Ovarian Cancer Growth through Dysregulated Cell Cycle, Diminished Apoptosis, and Enhanced Angiogenesis
CCR Translation for This Article from Neural Tumor-Initiating Cells Have Distinct Telomere Maintenance and Can be Safely Targeted for Telomerase Inhibition
Authors: Castelo-Branco Pedro , Zhang Cindy , Lipman Tatiana , Fujitani Mayumi , Hansford Loen , Clarke Ian , Harley Calvin B. , Tressler Robert , Malkin David , Walker Erin , Kaplan David R. , Dirks Peter , Tabori Uri
Published: April 2023

CCR Translation for This Article from Neural Tumor-Initiating Cells Have Distinct Telomere Maintenance and Can be Safely Targeted for Telomerase Inhibition
Supplementary Data from Large-Scale Analysis of KIT Aberrations in Chinese Patients with Melanoma
Authors: Kong Yan , Si Lu , Zhu Yanyan , Xu Xiaowei , Corless Christopher L. , Flaherty Keith T. , Li Li , Li Haifu , Sheng Xinan , Cui Chuanliang , Chi Zhihong , Li Siming , Han Mei , Mao Lili , Lu Aiping , Guo Jun
Published: April 2023

Supplementary Figures S1-S8; Supplementary Tables S1-S3.
Supplementary Figure 1 from Myeloid Biomarkers Associated with Glioblastoma Response to Anti-VEGF Therapy with Aflibercept
Authors: de Groot John F. , Piao Yuji , Tran Hai , Gilbert Mark , Wu Hua-Kang , Liu Jun , Bekele B. Nebiyou , Cloughesy Tim , Mehta Minesh , Robins H. Ian , Lassman Andrew , DeAngelis Lisa , Camphausen Kevin , Chen Alice , Yung WKA , Prados Michael , Wen Patrick Y. , Heymach John V.
Published: April 2023

Supplementary Figure 1 from Myeloid Biomarkers Associated with Glioblastoma Response to Anti-VEGF Therapy with Aflibercept
Supplementary Figures S1-S2 from mRNA and microRNA Expression Profiles in Circulating Tumor Cells and Primary Tumors of Metastatic Breast Cancer Patients
Authors: Sieuwerts Anieta M. , Mostert Bianca , Bolt-de Vries Joan , Peeters Dieter , de Jongh Felix E. , Stouthard Jacqueline M.L. , Dirix Luc Y. , van Dam Peter A. , Van Galen Anne , de Weerd Vanja , Kraan Jaco , van der Spoel Petra , Ramírez-Moreno Raquel , van Deurzen Carolien H.M. , Smid Marcel , Yu Jack X. , Jiang John , Wang Yixin , Gratama Jan W. , Sleijfer Stefan , Foekens John A. , Martens John W.M.
Published: April 2023

Supplementary Figures S1-S2 from mRNA and microRNA Expression Profiles in Circulating Tumor Cells and Primary Tumors of Metastatic Breast Cancer Patients
Supplementary Data from A Phase I Study of the Heat Shock Protein 90 Inhibitor Alvespimycin (17-DMAG) Given Intravenously to Patients with Advanced Solid Tumors
Authors: Pacey Simon , Wilson Richard H. , Walton Mike , Eatock Martin M. , Hardcastle Anthea , Zetterlund Anna , Arkenau Hendrik-Tobias , Moreno-Farre Javier , Banerji Udai , Roels Belle , Peachey Heidi , Aherne Wynne , de Bono Johan S. , Raynaud Florence , Workman Paul , Judson Ian
Published: April 2023

Supplementary Figures S1-S2; Supplementary Tables S1-S2.
Supplementary Data from In vitro and In vivo Selective Antitumor Activity of Edelfosine against Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia Involving Lipid Rafts
Authors: Mollinedo Faustino , de la Iglesia-Vicente Janis , Gajate Consuelo , de Mendoza Ander Estella-Hermoso , Villa-Pulgarin Janny A. , de Frias Mercè , Roué Gaël , Gil Joan , Colomer Dolors , Campanero Miguel A. , Blanco-Prieto Maria J.
Published: April 2023

Supplementary Data from In vitro and In vivo Selective Antitumor Activity of Edelfosine against Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia Involving Lipid Rafts
Supplementary Data from Activation of β-Catenin by Hypoxia in Hepatocellular Carcinoma Contributes to Enhanced Metastatic Potential and Poor Prognosis
Authors: Liu Liang , Zhu Xiao-Dong , Wang Wen-Quan , Shen Yuan , Qin Yi , Ren Zheng-Gang , Sun Hui-Chuan , Tang Zhao-You
Published: April 2023

Supplementary Data from Activation of β-Catenin by Hypoxia in Hepatocellular Carcinoma Contributes to Enhanced Metastatic Potential and Poor Prognosis
Supplementary Figures 1-3 from Programmed Death Ligand 1 Is Expressed by Non–Hodgkin Lymphomas and Inhibits the Activity of Tumor-Associated T Cells
Authors: Andorsky David J. , Yamada Reiko E. , Said Jonathan , Pinkus Geraldine S. , Betting David J. , Timmerman John M.
Published: April 2023

PDF file - 471K
Supplementary Data from Dual mTORC2/mTORC1 Targeting Results in Potent Suppressive Effects on Acute Myeloid Leukemia (AML) Progenitors
Authors: Altman Jessica K. , Sassano Antonella , Kaur Surinder , Glaser Heather , Kroczynska Barbara , Redig Amanda J. , Russo Suzanne , Barr Sharon , Platanias Leonidas C.
Published: April 2023

Supplementary Figures S1-S3; Supplementary Methods.
Related CCR Translation from Pharmacokinetics of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Locally Advanced or Metastatic Solid Tumors: the Role of Alpha-1-Acid Glycoprotein Binding
Authors: Graham Richard A. , Lum Bert L. , Cheeti Sravanthi , Jin Jin Yan , Jorga Karin , Von Hoff Daniel D. , Rudin Charles M. , Reddy Josina C. , Low Jennifer A. , LoRusso Patricia M.
Published: April 2023

Related CCR Translation from Pharmacokinetics of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Locally Advanced or Metastatic Solid Tumors: the Role of Alpha-1-Acid Glycoprotein Binding
Supplementary Table S7 from IL6-STAT3-HIF Signaling and Therapeutic Response to the Angiogenesis Inhibitor Sunitinib in Ovarian Clear Cell Cancer
Authors: Anglesio Michael S. , George Joshy , Kulbe Hagen , Friedlander Michael , Rischin Danny , Lemech Charlotte , Power Jeremy , Coward Jermaine , Cowin Prue A. , House Colin M. , Chakravarty Probir , Gorringe Kylie L. , Campbell Ian G. , Okamoto Aikou , Birrer Michael J. , Huntsman David G. , de Fazio Anna , Kalloger Steve E. , Balkwill Frances , Gilks C. Blake , Bowtell David D.
Published: April 2023

Supplementary Table S7.
Supplementary Table S3 from IL6-STAT3-HIF Signaling and Therapeutic Response to the Angiogenesis Inhibitor Sunitinib in Ovarian Clear Cell Cancer
Authors: Anglesio Michael S. , George Joshy , Kulbe Hagen , Friedlander Michael , Rischin Danny , Lemech Charlotte , Power Jeremy , Coward Jermaine , Cowin Prue A. , House Colin M. , Chakravarty Probir , Gorringe Kylie L. , Campbell Ian G. , Okamoto Aikou , Birrer Michael J. , Huntsman David G. , de Fazio Anna , Kalloger Steve E. , Balkwill Frances , Gilks C. Blake , Bowtell David D.
Published: April 2023

Supplementary Table S3.
Supplementary Data from Distinct p53 Gene Signatures Are Needed to Predict Prognosis and Response to Chemotherapy in ER-Positive and ER-Negative Breast Cancers
Authors: Coutant Charles , Rouzier Roman , Qi Yuan , Lehmann-Che Jacqueline , Bianchini Giampaolo , Iwamoto Takayuki , Hortobagyi Gabriel N. , Symmans W. Fraser , Uzan Serge , Andre Fabrice , de Thé Hugues , Pusztai Lajos
Published: April 2023

Supplementary Figures S1-S5; Supplementary Methods; Supplementary Tables S1-S6.
Supplementary Methods from IL6-STAT3-HIF Signaling and Therapeutic Response to the Angiogenesis Inhibitor Sunitinib in Ovarian Clear Cell Cancer
Authors: Anglesio Michael S. , George Joshy , Kulbe Hagen , Friedlander Michael , Rischin Danny , Lemech Charlotte , Power Jeremy , Coward Jermaine , Cowin Prue A. , House Colin M. , Chakravarty Probir , Gorringe Kylie L. , Campbell Ian G. , Okamoto Aikou , Birrer Michael J. , Huntsman David G. , de Fazio Anna , Kalloger Steve E. , Balkwill Frances , Gilks C. Blake , Bowtell David D.
Published: April 2023

Supplementary Methods.
Supplementary Video 3 from Cell Surface Delivery of TRAIL Strongly Augments the Tumoricidal Activity of T Cells
Authors: de Bruyn Marco , Wei Yunwei , Wiersma Valerie R. , Samplonius Douwe F. , Klip Harry G. , van der Zee Ate G.J. , Yang Baofeng , Helfrich Wijnand , Bremer Edwin
Published: April 2023

AVI file - 1941K
Supplementary Video 2 from Cell Surface Delivery of TRAIL Strongly Augments the Tumoricidal Activity of T Cells
Authors: de Bruyn Marco , Wei Yunwei , Wiersma Valerie R. , Samplonius Douwe F. , Klip Harry G. , van der Zee Ate G.J. , Yang Baofeng , Helfrich Wijnand , Bremer Edwin
Published: April 2023

AVI file - 9616K
Supplementary Figure S1 from Brain-Derived Neurotrophic Factor and Neurotrophin-4/5 Are Expressed in Breast Cancer and Can Be Targeted to Inhibit Tumor Cell Survival
Authors: Vanhecke Elsa , Adriaenssens Eric , Verbeke Stéphanie , Meignan Samuel , Germain Emmanuelle , Berteaux Nathalie , Nurcombe Victor , Le Bourhis Xuefen , Hondermarck Hubert
Published: April 2023

Supplementary Figure S1.
Supplementary Data from Two-Stage Phase I Dose-Escalation Study of Intratumoral Reovirus Type 3 Dearing and Palliative Radiotherapy in Patients with Advanced Cancers
Authors: Harrington Kevin J. , Karapanagiotou Eleni M. , Roulstone Victoria , Twigger Katie R. , White Christine L. , Vidal Laura , Beirne Debbie , Prestwich Robin , Newbold Kate , Ahmed Merina , Thway Khin , Nutting Christopher M. , Coffey Matt , Harris Dean , Vile Richard G. , Pandha Hardev S. , DeBono Johann S. , Melcher Alan A.
Published: April 2023

Supplementary Data from Two-Stage Phase I Dose-Escalation Study of Intratumoral Reovirus Type 3 Dearing and Palliative Radiotherapy in Patients with Advanced Cancers
Supplementary Figure 2 from Cell Surface Delivery of TRAIL Strongly Augments the Tumoricidal Activity of T Cells
Authors: de Bruyn Marco , Wei Yunwei , Wiersma Valerie R. , Samplonius Douwe F. , Klip Harry G. , van der Zee Ate G.J. , Yang Baofeng , Helfrich Wijnand , Bremer Edwin
Published: April 2023

PDF file - 324K
Supplementary Data from Benign Mesenchymal Stromal Cells in Human Sarcomas
Authors: Morozov Alexei , Downey Robert J. , Healey John , Moreira Andre L. , Lou Emil , Franceschino Anna , Dogan Yildirim , Leung Roland , Edgar Mark , LaQuaglia Michael , Maki Robert G. , Moore Malcolm A.S.
Published: April 2023

Supplementary Figure S1 and Supplementary Tables S1-S2.
Supplementary Table S1 from DNA Damage Persistence as Determinant of Tumor Sensitivity to the Combination of Topo I Inhibitors and Telomere-Targeting Agents
Authors: Biroccio Annamaria , Porru Manuela , Rizzo Angela , Salvati Erica , D'Angelo Carmen , Orlandi Augusto , Passeri Daniela , Franceschin Marco , Stevens Malcolm F.G. , Gilson Eric , Beretta Giovanni , Zupi Gabriella , Pisano Claudio , Zunino Franco , Leonetti Carlo
Published: April 2023

Supplementary Table S1.
Supplementary Table 1 from Route of Administration Modulates the Induction of Dendritic Cell Vaccine–Induced Antigen-Specific T Cells in Advanced Melanoma Patients
Authors: Lesterhuis W. Joost , de Vries I. Jolanda M. , Schreibelt Gerty , Lambeck Annechien J.A. , Aarntzen Erik H.J.G. , Jacobs Joannes F.M. , Scharenborg Nicole M. , van de Rakt Mandy W.M.M. , de Boer Annemiek J. , Croockewit Sandra , van Rossum Michelle M. , Mus Roel , Oyen Wim J.G. , Boerman Otto C. , Lucas Sophie , Adema Gosse J. , Punt Cornelis J.A. , Figdor Carl G.
Published: April 2023

PDF file - 92K, Immunological responses after DC vaccination.
Supplementary Figure 2 from Route of Administration Modulates the Induction of Dendritic Cell Vaccine–Induced Antigen-Specific T Cells in Advanced Melanoma Patients
Authors: Lesterhuis W. Joost , de Vries I. Jolanda M. , Schreibelt Gerty , Lambeck Annechien J.A. , Aarntzen Erik H.J.G. , Jacobs Joannes F.M. , Scharenborg Nicole M. , van de Rakt Mandy W.M.M. , de Boer Annemiek J. , Croockewit Sandra , van Rossum Michelle M. , Mus Roel , Oyen Wim J.G. , Boerman Otto C. , Lucas Sophie , Adema Gosse J. , Punt Cornelis J.A. , Figdor Carl G.
Published: April 2023

PDF file - 55K, Consort flow chart.
Supplementary Figure Legend from Inhibition of the Kit Ligand/c-Kit Axis Attenuates Metastasis in a Mouse Model Mimicking Local Breast Cancer Relapse after Radiotherapy
Authors: Kuonen François , Laurent Julien , Secondini Chiara , Lorusso Girieca , Stehle Jean-Christophe , Rausch Thierry , Faes-van't Hull Eveline , Bieler Grégory , Alghisi Gian-Carlo , Schwendener Reto , Andrejevic-Blant Snezana , Mirimanoff René-Olivier , Rüegg Curzio
Published: April 2023

PDF file, 111KB.
Supplementary Figure 1 from Route of Administration Modulates the Induction of Dendritic Cell Vaccine–Induced Antigen-Specific T Cells in Advanced Melanoma Patients
Authors: Lesterhuis W. Joost , de Vries I. Jolanda M. , Schreibelt Gerty , Lambeck Annechien J.A. , Aarntzen Erik H.J.G. , Jacobs Joannes F.M. , Scharenborg Nicole M. , van de Rakt Mandy W.M.M. , de Boer Annemiek J. , Croockewit Sandra , van Rossum Michelle M. , Mus Roel , Oyen Wim J.G. , Boerman Otto C. , Lucas Sophie , Adema Gosse J. , Punt Cornelis J.A. , Figdor Carl G.
Published: April 2023

PDF file - 41K, Clinical protocol and immunization schedule.
Supplementary Figure 7 from Inhibition of the Kit Ligand/c-Kit Axis Attenuates Metastasis in a Mouse Model Mimicking Local Breast Cancer Relapse after Radiotherapy
Authors: Kuonen François , Laurent Julien , Secondini Chiara , Lorusso Girieca , Stehle Jean-Christophe , Rausch Thierry , Faes-van't Hull Eveline , Bieler Grégory , Alghisi Gian-Carlo , Schwendener Reto , Andrejevic-Blant Snezana , Mirimanoff René-Olivier , Rüegg Curzio
Published: April 2023

PDF file, 81KB, Detection, depletion and inhibition of c-Kit-expressing cells.
Supplementary Data from Enhanced Safety Profiles of the Telomerase-Specific Replication-Competent Adenovirus by Incorporation of Normal Cell-Specific microRNA-Targeted Sequences
Authors: Sugio Kumiko , Sakurai Fuminori , Katayama Kazufumi , Tashiro Katsuhisa , Matsui Hayato , Kawabata Kenji , Kawase Atsushi , Iwaki Masahiro , Hayakawa Takao , Fujiwara Toshiyoshi , Mizuguchi Hiroyuki
Published: April 2023

Supplementary Figures S1-S3; Supplementary Table S1.
Supplementary Figure 4 from Inhibition of the Kit Ligand/c-Kit Axis Attenuates Metastasis in a Mouse Model Mimicking Local Breast Cancer Relapse after Radiotherapy
Authors: Kuonen François , Laurent Julien , Secondini Chiara , Lorusso Girieca , Stehle Jean-Christophe , Rausch Thierry , Faes-van't Hull Eveline , Bieler Grégory , Alghisi Gian-Carlo , Schwendener Reto , Andrejevic-Blant Snezana , Mirimanoff René-Olivier , Rüegg Curzio
Published: April 2023

PDF file, 92KB, KitL expression and KitL silencing in 4T1 tumors.
Supplementary Data from A Seven-Gene Set Associated with Chronic Hypoxia of Prognostic Importance in Hepatocellular Carcinoma
Authors: van Malenstein Hannah , Gevaert Olivier , Libbrecht Louis , Daemen Anneleen , Allemeersch Joke , Nevens Frederik , Van Cutsem Eric , Cassiman David , De Moor Bart , Verslype Chris , van Pelt Jos
Published: April 2023

Supplementary Figures S1-S5, Supplementary Materials and Methods, and Supplementary Tables S1-S4.
Supplementary Tables 1-2, Figures 1-10 from HER2-Affitoxin: A Potent Therapeutic Agent for the Treatment of HER2-Overexpressing Tumors
Authors: Zielinski Rafal , Lyakhov Ilya , Hassan Moinuddin , Kuban Monika , Shafer-Weaver Kimberly , Gandjbakhche Amir , Capala Jacek
Published: April 2023

PDF file - 723K
Supplementary Table S4 from Gene Signatures for the Prediction of Response to Bacillus Calmette-Guérin Immunotherapy in Primary pT1 Bladder Cancers
Authors: Kim Yong-June , Ha Yun-Sok , Kim Seon-Kyu , Yoon Hyung Yoon , Lym Min Su , Kim Min-Ju , Moon Sung-Kwon , Choi Yung Hyun , Kim Wun-Jae
Published: April 2023

Supplementary Table S4 from Gene Signatures for the Prediction of Response to Bacillus Calmette-Guérin Immunotherapy in Primary pT1 Bladder Cancers
Supplementary Data from Combination of Farnesyltransferase and Akt Inhibitors Is Synergistic in Breast Cancer Cells and Causes Significant Breast Tumor Regression in ErbB2 Transgenic Mice
Authors: Balasis Maria E. , Forinash Kara D. , Chen Y. Ann , Fulp William J. , Coppola Domenico , Hamilton Andrew D. , Cheng Jin Q. , Sebti Saïd M.
Published: April 2023

Supplementary Figures S1-S2; Supplementary Tables S1-S3.
Supplementary Data from Digital Transcript Profile Analysis with aRNA-LongSAGE Validates FERMT1 As a Potential Novel Prognostic Marker for Colon Cancer
Authors: Fan Junwei , Yan Dongwang , Teng Mujian , Tang Huamei , Zhou Chongzhi , Wang Xiaoliang , Li Dawei , Qiu Guoqiang , Peng Zhihai
Published: April 2023

Supplementary Figures S1-S3; Supplementary Tables S1-S4.
Supplementary Data from Lenalidomide Restrains Motility and Overangiogenic Potential of Bone Marrow Endothelial Cells in Patients with Active Multiple Myeloma
Authors: De Luisi Annunziata , Ferrucci Arianna , Coluccia Addolorata M.L. , Ria Roberto , Moschetta Michele , de Luca Emanuela , Pieroni Luisa , Maffia Michele , Urbani Andrea , Di Pietro Giulia , Guarini Attilio , Ranieri Girolamo , Ditonno Paolo , Berardi Simona , Caivano Antonella , Basile Antonio , Cascavilla Nicola , Capalbo Silvana , Quarta Giovanni , Dammacco Franco , Ribatti Domenico , Vacca Angelo
Published: April 2023

Supplementary Figures S1-S4; Supplementary Table S1.
Supplementary Data from Reproducibility of [11C]Choline-Positron Emission Tomography and Effect of Trastuzumab
Authors: Kenny Laura M. , Contractor Kaiyumars B. , Hinz Rainer , Stebbing Justin , Palmieri Carlo , Jiang Jie , Shousha Sami , Al-Nahhas Adil , Coombes R. Charles , Aboagye Eric O.
Published: April 2023

Supplementary Figures S1-S2 and Supplementary Table S1.
Supplementary Figure 1 from Gastric Cancer Growth Control by BEZ235 In Vivo Does Not Correlate with PI3K/mTOR Target Inhibition but with [18F]FLT Uptake
Authors: Fuereder Thorsten , Wanek Thomas , Pflegerl Pamina , Jaeger-Lansky Agnes , Hoeflmayer Doris , Strommer Sabine , Kuntner Claudia , Wrba Friedrich , Werzowa Johannes , Hejna Michael , Müller Markus , Langer Oliver , Wacheck Volker
Published: April 2023

PDF file - 631K
Supplementary Data from Subtype-Specific FBXW7 Mutation and MYCN Copy Number Gain in Wilms' Tumor
Authors: Williams Richard D. , Al-Saadi Reem , Chagtai Tasnim , Popov Sergey , Messahel Boo , Sebire Neil , Gessler Manfred , Wegert Jenny , Graf Norbert , Leuschner Ivo , Hubank Mike , Jones Chris , Vujanic Gordan , Pritchard-Jones Kathy
Published: April 2023

Supplementary Data from Subtype-Specific FBXW7 Mutation and MYCN Copy Number Gain in Wilms' Tumor
Related Article from The Tissue Is the Issue: Personalized Medicine for Non-Small Cell Lung Cancer
Authors: Hirsch Fred R. , Wynes Murry W. , Gandara David R. , Bunn Paul A.
Published: April 2023

Related Article from The Tissue Is the Issue: Personalized Medicine for Non-Small Cell Lung Cancer
Supplementary Data from A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor–Positive Breast Cancer
Authors: Nielsen Torsten O. , Parker Joel S. , Leung Samuel , Voduc David , Ebbert Mark , Vickery Tammi , Davies Sherri R. , Snider Jacqueline , Stijleman Inge J. , Reed Jerry , Cheang Maggie C.U. , Mardis Elaine R. , Perou Charles M. , Bernard Philip S. , Ellis Matthew J.
Published: April 2023

Supplementary Data from A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor–Positive Breast Cancer
Supplementary Data from Heat Shock Protein 90-Sheltered Overexpression of Insulin-Like Growth Factor 1 Receptor Contributes to Malignancy of Thymic Epithelial Tumors
Authors: Breinig Marco , Mayer Philipp , Harjung Andreas , Goeppert Benjamin , Malz Mona , Penzel Roland , Neumann Olaf , Hartmann Arndt , Dienemann Hendrik , Giaccone Giuseppe , Schirmacher Peter , Kern Michael André , Chiosis Gabriela , Rieker Ralf Joachim
Published: April 2023

Supplementary Figures S1-S8; Supplementary Methods; Supplementary Tables S1-S3.
Supplementary Data from Microenvironmental Regulation of Glioblastoma Radioresponse
Authors: Jamal Muhammad , Rath Barbara H. , Williams Eli S. , Camphausen Kevin , Tofilon Philip J.
Published: April 2023

Supplementary Tables S1-S2.
Supplementary Data from TKTL1 Is Activated by Promoter Hypomethylation and Contributes to Head and Neck Squamous Cell Carcinoma Carcinogenesis through Increased Aerobic Glycolysis and HIF1α Stabilization
Authors: Sun Wenyue , Liu Yan , Glazer Chad A. , Shao Chunbo , Bhan Sheetal , Demokan Semra , Zhao Ming , Rudek Michelle A. , Ha Patrick K. , Califano Joseph A.
Published: April 2023

Supplementary Data from TKTL1 Is Activated by Promoter Hypomethylation and Contributes to Head and Neck Squamous Cell Carcinoma Carcinogenesis through Increased Aerobic Glycolysis and HIF1α Stabilization
Supplementary Table S1 from The Progression from MGUS to Smoldering Myeloma and Eventually to Multiple Myeloma Involves a Clonal Expansion of Genetically Abnormal Plasma Cells
Authors: López-Corral Lucía , Gutiérrez Norma C. , Vidriales Maria Belén , Mateos Maria Victoria , Rasillo Ana , García-Sanz Ramón , Paiva Bruno , San Miguel Jesús F.
Published: April 2023

Supplementary Table S1.
Supplementary Methods from The Novel HSP90 Inhibitor, IPI-493, Is Highly Effective in Human Gastrostrointestinal Stromal Tumor Xenografts Carrying Heterogeneous KIT Mutations
Authors: Floris Giuseppe , Sciot Raf , Wozniak Agnieszka , Van Looy Thomas , Wellens Jasmien , Faa Gavino , Normant Emmanuel , Debiec-Rychter Maria , Schöffski Patrick
Published: April 2023

PDF file - 117K
Supplementary Figure 2 from The Novel HSP90 Inhibitor, IPI-493, Is Highly Effective in Human Gastrostrointestinal Stromal Tumor Xenografts Carrying Heterogeneous KIT Mutations
Authors: Floris Giuseppe , Sciot Raf , Wozniak Agnieszka , Van Looy Thomas , Wellens Jasmien , Faa Gavino , Normant Emmanuel , Debiec-Rychter Maria , Schöffski Patrick
Published: April 2023

PDF file - 21K
Supplementary Figures S1-S3 from Cancer Patients Treated with Sunitinib or Sorafenib Have Sufficient Antibody and Cellular Immune Responses to Warrant Influenza Vaccination
Authors: Mulder Sasja F. , Jacobs Joannes F.M. , Olde Nordkamp Michel A.M. , Galama Joep M.D. , Desar Ingrid M.E. , Torensma Ruurd , Teerenstra Steven , Mulders Peter F.A. , Vissers Kris C.P. , Punt Cornelis J.A. , de Vries I. Jolanda M. , van Herpen Carla M.L.
Published: April 2023

Supplementary Figures S1-S3 from Cancer Patients Treated with Sunitinib or Sorafenib Have Sufficient Antibody and Cellular Immune Responses to Warrant Influenza Vaccination
Supplementary Data from Three Epigenetic Biomarkers, GDF15, TMEFF2, and VIM, Accurately Predict Bladder Cancer from DNA-Based Analyses of Urine Samples
Authors: Costa Vera L. , Henrique Rui , Danielsen Stine A. , Duarte-Pereira Sara , Eknaes Mette , Skotheim Rolf I. , Rodrigues Ângelo , Magalhães José S. , Oliveira Jorge , Lothe Ragnhild A. , Teixeira Manuel R. , Jerónimo Carmen , Lind Guro E.
Published: April 2023

Supplementary Figures S1-S4 and Supplementary Tables S1-S7.
Supplementary Figure 2 from Outcome of Patients with Platelet-Derived Growth Factor Receptor Alpha–Mutated Gastrointestinal Stromal Tumors in the Tyrosine Kinase Inhibitor Era
Authors: Cassier Philippe A. , Fumagalli Elena , Rutkowski Piotr , Schöffski Patrick , Van Glabbeke Martine , Debiec-Rychter Maria , Emile Jean-François , Duffaud Florence , Martin-Broto Javier , Landi Bruno , Adenis Antoine , Bertucci François , Bompas Emmanuelle , Bouché Olivier , Leyvraz Serge , Judson Ian , Verweij Jaap , Casali Paolo , Blay Jean-Yves , Hohenberger Peter
Published: April 2023

PDF file, 60KB, Progression-free (panel A) and overall (panel B) survival according to the mitosis count. HPF: high power field.
Supplementary Movie S1 from Noninvasive Radiofrequency Field Destruction of Pancreatic Adenocarcinoma Xenografts Treated with Targeted Gold Nanoparticles
Authors: Glazer Evan S. , Zhu Cihui , Massey Katheryn L. , Thompson C. Shea , Kaluarachchi Warna D. , Hamir Amir N. , Curley Steven A.
Published: April 2023

Supplementary Movie S1.
Supplementary Data from Preclinical Evaluation of Telomerase-Specific Oncolytic Virotherapy for Human Bone and Soft Tissue Sarcomas
Authors: Sasaki Tsuyoshi , Tazawa Hiroshi , Hasei Jo , Kunisada Toshiyuki , Yoshida Aki , Hashimoto Yuuri , Yano Shuya , Yoshida Ryosuke , Uno Futoshi , Kagawa Shunsuke , Morimoto Yuki , Urata Yasuo , Ozaki Toshifumi , Fujiwara Toshiyoshi
Published: April 2023

Supplementary Figures S1-S5; Supplementary Table S1.
Supplementary Data from Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Lung Cancer: Distinct Natural History of Patients with Tumors Harboring the T790M Mutation
Authors: Oxnard Geoffrey R. , Arcila Maria E. , Sima Camelia S. , Riely Gregory J. , Chmielecki Juliann , Kris Mark G. , Pao William , Ladanyi Marc , Miller Vincent A.
Published: April 2023

Supplementary Figures S1-S2.
Related Article from Barriers to Integrating Gene Profiling for Stage II Colon Cancer
Authors: Kopetz Scott , Abbruzzese James L.
Published: April 2023

Related Article from Barriers to Integrating Gene Profiling for Stage II Colon Cancer
Supplementary Table S4 from Clinical Implications of Gene Dosage and Gene Expression Patterns in Diploid Breast Carcinoma
Authors: Parris Toshima Z. , Danielsson Anna , Nemes Szilárd , Kovács Anikó , Delle Ulla , Fallenius Ghita , Möllerström Elin , Karlsson Per , Helou Khalil
Published: April 2023

Supplementary Table S4 from Clinical Implications of Gene Dosage and Gene Expression Patterns in Diploid Breast Carcinoma
Supplementary Data from Pharmacokinetic Analysis and Phase 1 Study of MRX-1024 in Patients Treated with Radiation Therapy with or without Cisplatinum for Head and Neck Cancer
Authors: Hamstra Daniel A. , Eisbruch Avraham , Naidu Maddireddy U.R. , Ramana Gogula V. , Sunkara Prasad , Campbell Kathleen C.M. , Ross Brian D. , Rehemtulla Alnawaz
Published: April 2023

Supplementary Data from Pharmacokinetic Analysis and Phase 1 Study of MRX-1024 in Patients Treated with Radiation Therapy with or without Cisplatinum for Head and Neck Cancer
Supplementary Data from Clinical Implications of Gene Dosage and Gene Expression Patterns in Diploid Breast Carcinoma
Authors: Parris Toshima Z. , Danielsson Anna , Nemes Szilárd , Kovács Anikó , Delle Ulla , Fallenius Ghita , Möllerström Elin , Karlsson Per , Helou Khalil
Published: April 2023

Supplementary Data from Clinical Implications of Gene Dosage and Gene Expression Patterns in Diploid Breast Carcinoma
Supplementary Data from Foxo3a Suppression of Urothelial Cancer Invasiveness through Twist1, Y-Box–Binding Protein 1, and E-Cadherin Regulation
Authors: Shiota Masaki , Song YooHyun , Yokomizo Akira , Kiyoshima Keijiro , Tada Yasuhiro , Uchino Hiroshi , Uchiumi Takeshi , Inokuchi Junichi , Oda Yoshinao , Kuroiwa Kentaro , Tatsugami Katsunori , Naito Seiji
Published: April 2023

Supplementary Tables S1-S2.
Supplementary Table 4 from Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer
Authors: Coward Jermaine , Kulbe Hagen , Chakravarty Probir , Leader David , Vassileva Vessela , Leinster D. Andrew , Thompson Richard , Schioppa Tiziana , Nemeth Jeffery , Vermeulen Jessica , Singh Naveena , Avril Norbert , Cummings Jeff , Rexhepaj Elton , Jirström Karin , Gallagher William M. , Brennan Donal J. , McNeish Iain A. , Balkwill Frances R.
Published: April 2023

XLS file - 78K
Supplementary Methods, Figures 1-3 from Killing of Resistant Cancer Cells with Low Bak by a Combination of an Antimesothelin Immunotoxin and a TRAIL Receptor 2 Agonist Antibody
Authors: Du Xing , Xiang Laiman , Mackall Crystal , Pastan Ira
Published: April 2023

PDF file - 405K
Supplementary Data from Antitumor Activity of SNX-2112, a Synthetic Heat Shock Protein-90 Inhibitor, in MET-Amplified Tumor Cells with or without Resistance to Selective MET Inhibition
Authors: Bachleitner-Hofmann Thomas , Sun Mark Y. , Chen Chin-Tung , Liska David , Zeng Zhaoshi , Viale Agnes , Olshen Adam B. , Mittlboeck Martina , Christensen James G. , Rosen Neal , Solit David B. , Weiser Martin R.
Published: April 2023

Supplementary Figures S1-S2; Supplementary Table S1.
Supplementary Data from Clinical Benefit of Lapatinib-Based Therapy in Patients with Human Epidermal Growth Factor Receptor 2–Positive Breast Tumors Coexpressing the Truncated p95HER2 Receptor
Authors: Scaltriti Maurizio , Chandarlapaty Sarat , Prudkin Ludmila , Aura Claudia , Jimenez José , Angelini Pier Davide , Sánchez Gertrudis , Guzman Marta , Parra Josep Lluis , Ellis Catherine , Gagnon Robert , Koehler Maria , Gomez Henry , Geyer Charles , Cameron David , Arribas Joaquin , Rosen Neal , Baselga José
Published: April 2023

Supplementary Data from Clinical Benefit of Lapatinib-Based Therapy in Patients with Human Epidermal Growth Factor Receptor 2–Positive Breast Tumors Coexpressing the Truncated p95HER2 Receptor
Supplementary Figures 1-5, Table 1 from Targeting GPCR-Mediated p70S6K Activity May Improve Head and Neck Cancer Response to Cetuximab
Authors: Bhola Neil E. , Thomas Sufi M. , Freilino Maria , Joyce Sonali , Sahu Anirban , Maxwell Jessica , Argiris Athanassios , Seethala Raja , Grandis Jennifer R.
Published: April 2023

PDF file - 294K, Targeting GPCR-mediated p70S6K activity may improve head and neck cancer response to cetuximab supplemental.
Supplementary Data from Hypermethylation of CpG Islands and Shores around Specific MicroRNAs and Mirtrons Is Associated with the Phenotype and Presence of Bladder Cancer
Authors: Dudziec Ewa , Miah Saiful , Choudhry Hani M.Z , Owen Helen C. , Blizard Sheila , Glover Maggie , Hamdy Freddie C. , Catto James W.F.
Published: April 2023

Supplementary Figures S1-S8.
Supplementary Data from Tumor-Infiltrating Macrophages Are Associated with Metastasis Suppression in High-Grade Osteosarcoma: A Rationale for Treatment with Macrophage Activating Agents
Authors: Buddingh Emilie P. , Kuijjer Marieke L. , Duim Ronald A.J. , Bürger Horst , Agelopoulos Konstantin , Myklebost Ola , Serra Massimo , Mertens Fredrik , Hogendoorn Pancras C.W. , Lankester Arjan C. , Cleton-Jansen Anne-Marie
Published: April 2023

Supplementary Figures S1-S4; Supplementary Tables S1-S5.
Supplementary Figure 4 from Atu027 Prevents Pulmonary Metastasis in Experimental and Spontaneous Mouse Metastasis Models
Authors: Santel Ansgar , Aleku Manuela , Röder Nadine , Möpert Kristin , Durieux Birgit , Janke Oliver , Keil Oliver , Endruschat Jens , Dames Sibylle , Lange Christian , Eisermann Mona , Löffler Kathrin , Fechtner Melanie , Fisch Gerald , Vank Christiane , Schaeper Ute , Giese Klaus , Kaufmann Jörg
Published: April 2023

PDF file - 174K
Supplementary Figure 3 from Atu027 Prevents Pulmonary Metastasis in Experimental and Spontaneous Mouse Metastasis Models
Authors: Santel Ansgar , Aleku Manuela , Röder Nadine , Möpert Kristin , Durieux Birgit , Janke Oliver , Keil Oliver , Endruschat Jens , Dames Sibylle , Lange Christian , Eisermann Mona , Löffler Kathrin , Fechtner Melanie , Fisch Gerald , Vank Christiane , Schaeper Ute , Giese Klaus , Kaufmann Jörg
Published: April 2023

PDF file - 82K
Supplementary Figures S1-S2 from NF1 Inactivation in Adult Acute Myelogenous Leukemia
Authors: Parkin Brian , Ouillette Peter , Wang Yin , Liu Yan , Wright Whitney , Roulston Diane , Purkayastha Anjali , Dressel Amanda , Karp Judith , Bockenstedt Paula , Al-Zoubi Ammar , Talpaz Moshe , Kujawski Lisa , Liu Yang , Shedden Kerby , Shakhan Sajid , Li Cheng , Erba Harry , Malek Sami N.
Published: April 2023

Supplementary Figures S1-S2 from NF1 Inactivation in Adult Acute Myelogenous Leukemia
Supplementary Figure S1 from The Activity of Trabectedin As a Single Agent or in Combination with Everolimus for Clear Cell Carcinoma of the Ovary
Authors: Mabuchi Seiji , Hisamatsu Takeshi , Kawase Chiaki , Hayashi Masami , Sawada Kenjiro , Mimura Kazuya , Takahashi Kazuhiro , Takahashi Toshifumi , Kurachi Hirohisa , Kimura Tadashi
Published: April 2023

Supplementary Figure S1 from The Activity of Trabectedin As a Single Agent or in Combination with Everolimus for Clear Cell Carcinoma of the Ovary
Supplementary Data from Genomic Profiling Reveals Alternative Genetic Pathways of Meningioma Malignant Progression Dependent on the Underlying NF2 Status
Authors: Goutagny Stéphane , Yang Hong Wei , Zucman-Rossi Jessica , Chan Jennifer , Dreyfuss Jonathan M. , Park Peter J. , Black Peter M. , Giovannini Marco , Carroll Rona S. , Kalamarides Michel
Published: April 2023

Supplementary Table S1.
Supplementary Figure S1 from Analysis of MiR-195 and MiR-497 Expression, Regulation and Role in Breast Cancer
Authors: Li Dan , Zhao Yulan , Liu Changxing , Chen Xiaona , Qi Yanting , Jiang Yue , Zou Chao , Zhang Xiaolong , Liu Shunying , Wang Xuejing , Zhao Dan , Sun Qiang , Zeng Zhenbing , Dress Andreas , Lin Marie C. , Kung Hsiang-Fu , Rui Hallgeir , Liu Ling-Zhi , Mao Feng , Jiang Bing-Hua , Lai Lihui
Published: April 2023

Supplementary Figure S1.
Supplementary Data from Development of Autoantibody Signatures as Novel Diagnostic Biomarkers of Non–Small Cell Lung Cancer
Authors: Wu Lingling , Chang Wenjun , Zhao Jinfeng , Yu Yongwei , Tan Xiaojie , Su Tong , Zhao Lijun , Huang Shengdong , Liu Shiyuan , Cao Guangwen
Published: April 2023

Supplementary Tables S1-S7.
Supplementary Data from Near IR Heptamethine Cyanine Dye–Mediated Cancer Imaging
Authors: Yang Xiaojian , Shi Chunmeng , Tong Rong , Qian Weiping , Zhau Haiyen E. , Wang Ruoxiang , Zhu Guodong , Cheng Jianjun , Yang Vincent W. , Cheng Tianmin , Henary Maged , Strekowski Lucjan , Chung Leland W.K.
Published: April 2023

Supplementary Data from Near IR Heptamethine Cyanine Dye–Mediated Cancer Imaging
Supplementary Figures 1 - 5 from PF-03732010: A Fully Human Monoclonal Antibody against P-Cadherin with Antitumor and Antimetastatic Activity
Authors: Zhang Cathy C. , Yan Zhengming , Zhang Qin , Kuszpit Kyle , Zasadny Kenneth , Qiu Ming , Painter Cory L. , Wong Anthony , Kraynov Eugenia , Arango Maria E. , Mehta Pramod P. , Popoff Ian , Casperson Gerald F. , Los Gerrit , Bender Steve , Anderes Kenna , Christensen James G. , VanArsdale Todd
Published: April 2023

Supplementary Figures 1 - 5 from PF-03732010: A Fully Human Monoclonal Antibody against P-Cadherin with Antitumor and Antimetastatic Activity
Supplementary Data from Biological Evidence for Dual Antiangiogenic-Antiaromatase Activity of the VEGFR Inhibitor PTK787/ZK222584 In vivo
Authors: Banerjee Susana , A'Hern Roger , Detre Simone , Littlewood-Evans Amanda J. , Evans Dean B. , Dowsett Mitchell , Martin Lesley-Ann
Published: April 2023

Supplementary Figure S1.
Supplementary Data from FUS-CREB3L2/L1–Positive Sarcomas Show a Specific Gene Expression Profile with Upregulation of CD24 and FOXL1
Authors: Möller Emely , Hornick Jason L. , Magnusson Linda , Veerla Srinivas , Domanski Henryk A. , Mertens Fredrik
Published: April 2023

Supplementary Figures S1-S4; Supplementary Tables S1-S2.
Supplementary Data from CD8+ Enriched “Young” Tumor Infiltrating Lymphocytes Can Mediate Regression of Metastatic Melanoma
Authors: Dudley Mark E. , Gross Colin A. , Langhan Michelle M. , Garcia Marcos R. , Sherry Richard M. , Yang James C. , Phan Giao Q. , Kammula Udai S. , Hughes Marybeth S. , Citrin Deborah E. , Restifo Nicholas P. , Wunderlich John R. , Prieto Peter A. , Hong Jenny J. , Langan Russell C. , Zlott Daniel A. , Morton Kathleen E. , White Donald E. , Laurencot Carolyn M. , Rosenberg Steven A.
Published: April 2023

Supplementary Figure S1; Supplementary Table S1.
Supplementary Data from Role and Relevance of TrkB Mutations and Expression in Non–Small Cell Lung Cancer
Authors: Harada Taishi , Yatabe Yasushi , Takeshita Masafumi , Koga Takaomi , Yano Tokujiro , Wang Yisong , Giaccone Giuseppe
Published: April 2023

Supplementary Figure S1; Supplementary Table S1.
Supplementary Methods, Figure Legends 1-3, Tables 1A-B from Engineered Thio-Trastuzumab-DM1 Conjugate with an Improved Therapeutic Index to Target Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
Authors: Junutula Jagath R. , Flagella Kelly M. , Graham Richard A. , Parsons Kathryn L. , Ha Edward , Raab Helga , Bhakta Sunil , Nguyen Trung , Dugger Debra L. , Li Guangmin , Mai Elaine , Lewis Phillips Gail D. , Hiraragi Hajime , Fuji Reina N. , Tibbitts Jay , Vandlen Richard , Spencer Susan D. , Scheller Richard H. , Polakis Paul , Sliwkowski Mark X.
Published: April 2023

Supplementary Methods, Figure Legends 1-3, Tables 1A-B from Engineered Thio-Trastuzumab-DM1 Conjugate with an Improved Therapeutic Index to Target Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
Supplementary Figure 3C-D from Engineered Thio-Trastuzumab-DM1 Conjugate with an Improved Therapeutic Index to Target Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
Authors: Junutula Jagath R. , Flagella Kelly M. , Graham Richard A. , Parsons Kathryn L. , Ha Edward , Raab Helga , Bhakta Sunil , Nguyen Trung , Dugger Debra L. , Li Guangmin , Mai Elaine , Lewis Phillips Gail D. , Hiraragi Hajime , Fuji Reina N. , Tibbitts Jay , Vandlen Richard , Spencer Susan D. , Scheller Richard H. , Polakis Paul , Sliwkowski Mark X.
Published: April 2023

Supplementary Figure 3C-D from Engineered Thio-Trastuzumab-DM1 Conjugate with an Improved Therapeutic Index to Target Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
Supplementary Figure 3A-B from Engineered Thio-Trastuzumab-DM1 Conjugate with an Improved Therapeutic Index to Target Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
Authors: Junutula Jagath R. , Flagella Kelly M. , Graham Richard A. , Parsons Kathryn L. , Ha Edward , Raab Helga , Bhakta Sunil , Nguyen Trung , Dugger Debra L. , Li Guangmin , Mai Elaine , Lewis Phillips Gail D. , Hiraragi Hajime , Fuji Reina N. , Tibbitts Jay , Vandlen Richard , Spencer Susan D. , Scheller Richard H. , Polakis Paul , Sliwkowski Mark X.
Published: April 2023

Supplementary Figure 3A-B from Engineered Thio-Trastuzumab-DM1 Conjugate with an Improved Therapeutic Index to Target Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
Related Article from A New Mechanism for Blocking Myeloid-Derived Suppressor Cells by CpG
Authors: Lechner Melissa G. , Epstein Alan L.
Published: April 2023

Related Article from A New Mechanism for Blocking Myeloid-Derived Suppressor Cells by CpG
Supplementary Data from Anti-GD3 Chimeric sFv-CD28/T-Cell Receptor ζ Designer T Cells for Treatment of Metastatic Melanoma and Other Neuroectodermal Tumors
Authors: Lo Agnes S.Y. , Ma Qiangzhong , Liu David L. , Junghans Richard P.
Published: April 2023

Supplementary Data from Anti-GD3 Chimeric sFv-CD28/T-Cell Receptor ζ Designer T Cells for Treatment of Metastatic Melanoma and Other Neuroectodermal Tumors
Supplementary Figure S1 from Wnt/β-Catenin Signaling in T-Cell Immunity and Cancer Immunotherapy
Authors: Gattinoni Luca , Ji Yun , Restifo Nicholas P.
Published: April 2023

Supplementary Figure S1 from Wnt/β-Catenin Signaling in T-Cell Immunity and Cancer Immunotherapy
Supplementary Data from Anti-inflammatory Triterpenoid Blocks Immune Suppressive Function of MDSCs and Improves Immune Response in Cancer
Authors: Nagaraj Srinivas , Youn Je-In , Weber Hannah , Iclozan Cristina , Lu Lily , Cotter Matthew J. , Meyer Colin , Becerra Carlos R. , Fishman Mayer , Antonia Scott , Sporn Michael B. , Liby Karen T. , Rawal Bhupendra , Lee Ji-Hyun , Gabrilovich Dmitry I.
Published: April 2023

Supplementary Data from Anti-inflammatory Triterpenoid Blocks Immune Suppressive Function of MDSCs and Improves Immune Response in Cancer
Supplementary Table 1 from Brivanib, a Dual FGF/VEGF Inhibitor, Is Active Both First and Second Line against Mouse Pancreatic Neuroendocrine Tumors Developing Adaptive/Evasive Resistance to VEGF Inhibition
Authors: Allen Elizabeth , Walters Ian B. , Hanahan Douglas
Published: April 2023

PDF file - 60K
Supplementary Figure 3B from Brivanib, a Dual FGF/VEGF Inhibitor, Is Active Both First and Second Line against Mouse Pancreatic Neuroendocrine Tumors Developing Adaptive/Evasive Resistance to VEGF Inhibition
Authors: Allen Elizabeth , Walters Ian B. , Hanahan Douglas
Published: April 2023

PDF file - 49K
Supplementary Figure 1 from T-Cell Immune Function in Tumor, Skin, and Peripheral Blood of Advanced Stage Melanoma Patients: Implications for Immunotherapy
Authors: Tjin Esther P.M. , Konijnenberg Debby , Krebbers Gabrielle , Mallo Henk , Drijfhout Jan W. , Franken Kees L.M.C. , van der Horst Chantal M.A.M. , Bos Jan D. , Nieweg Omgo E. , Kroon Bin B.R. , Haanen John B.A.G. , Melief Cornelis J.M. , Vyth-Dreese Florry A. , Luiten Rosalie M.
Published: April 2023

PDF file - 5666K
Supplementary Figure 2A from Brivanib, a Dual FGF/VEGF Inhibitor, Is Active Both First and Second Line against Mouse Pancreatic Neuroendocrine Tumors Developing Adaptive/Evasive Resistance to VEGF Inhibition
Authors: Allen Elizabeth , Walters Ian B. , Hanahan Douglas
Published: April 2023

PDF file - 41K
Supplementary Data 3 from Merkel Cell Polyomavirus Infection, Large T Antigen, Retinoblastoma Protein and Outcome in Merkel Cell Carcinoma
Authors: Sihto Harri , Kukko Heli , Koljonen Virve , Sankila Risto , Böhling Tom , Joensuu Heikki
Published: April 2023

Supplementary Data 3 from Merkel Cell Polyomavirus Infection, Large T Antigen, Retinoblastoma Protein and Outcome in Merkel Cell Carcinoma
Supplementary Data 2 from Merkel Cell Polyomavirus Infection, Large T Antigen, Retinoblastoma Protein and Outcome in Merkel Cell Carcinoma
Authors: Sihto Harri , Kukko Heli , Koljonen Virve , Sankila Risto , Böhling Tom , Joensuu Heikki
Published: April 2023

Supplementary Data 2 from Merkel Cell Polyomavirus Infection, Large T Antigen, Retinoblastoma Protein and Outcome in Merkel Cell Carcinoma
Supplementary Figures S1-S5 from Plasma Markers for Identifying Patients with Metastatic Melanoma
Authors: Kluger Harriet M. , Hoyt Kathleen , Bacchiocchi Antonella , Mayer Tina , Kirsch Jonathan , Kluger Yuval , Sznol Mario , Ariyan Stephan , Molinaro Annette , Halaban Ruth
Published: April 2023

Supplementary Figures S1-S5.
Related Article from Molecular Targeting of Neural Cancer Stem Cells: TTAGGG, You're It!
Authors: Hjelmeland Anita B. , Rich Jeremy N.
Published: April 2023

Related Article from Molecular Targeting of Neural Cancer Stem Cells: TTAGGG, You're It!
Related Article from Overcoming Antiangiogenic Resistance
Authors: Yao James C. , Phan Alexandria
Published: April 2023

Related Article from Overcoming Antiangiogenic Resistance
Supplementary Data from Combined Promoter Methylation Analysis of CADM1 and MAL: An Objective Triage Tool for High-Risk Human Papillomavirus DNA–Positive Women
Authors: Hesselink Albertus T. , Heideman Daniëlle AM , Steenbergen Renske DM , Coupé Veerle M.H. , Overmeer Renee M. , Rijkaart Dorien , Berkhof Johannes , Meijer Chris J.L.M. , Snijders Peter J.F.
Published: April 2023

Supplementary Figures S1-S3; Supplementary Table S1.
Supplementary Figures S1-S3 from Local Activation of CD8 T Cells and Systemic Tumor Eradication without Toxicity via Slow Release and Local Delivery of Agonistic CD40 Antibody
Authors: Fransen Marieke F. , Sluijter Marjolein , Morreau Hans , Arens Ramon , Melief Cornelis J.M.
Published: April 2023

Supplementary Figures S1-S3.
Supplementary Data from Combination Therapy of Bortezomib with Novel Targeted Agents: An Emerging Treatment Strategy
Authors: Wright John J.
Published: April 2023

Supplementary Tables S1-S3.
Supplementary Data from Nelfinavir Induces Liposarcoma Apoptosis through Inhibition of Regulated Intramembrane Proteolysis of SREBP-1 and ATF6
Authors: Guan Min , Fousek Kristen , Jiang Chunling , Guo Song , Synold Tim , Xi Bixin , Shih Chu-Chih , Chow Warren A.
Published: April 2023

Supplementary Figures S1-S4.
Supplementary Figure 4 from Comparison of Clinical and Immunological Effects of Intravenous and Intradermal Administration of α-GalactosylCeramide (KRN7000)-Pulsed Dendritic Cells
Authors: Nicol Andrew J. , Tazbirkova Andrea , Nieda Mie
Published: April 2023

PDF file - 172K
Supplementary Table 3 from Evaluation of a 30-Gene Paclitaxel, Fluorouracil, Doxorubicin, and Cyclophosphamide Chemotherapy Response Predictor in a Multicenter Randomized Trial in Breast Cancer
Authors: Tabchy Adel , Valero Vicente , Vidaurre Tatiana , Lluch Ana , Gomez Henry , Martin Miguel , Qi Yuan , Barajas-Figueroa Luis Javier , Souchon Eduardo , Coutant Charles , Doimi Franco D. , Ibrahim Nuhad K. , Gong Yun , Hortobagyi Gabriel N. , Hess Kenneth R. , Symmans W. Fraser , Pusztai Lajos
Published: April 2023

XLS file - 57K, Top 206 candidate probesets on the U133A array with logistic regression interaction p-value<0.05 for the gene-treatment interaction effect that could differentially predict response by treatment arm.
Supplementary Figure 3 from Comparison of Clinical and Immunological Effects of Intravenous and Intradermal Administration of α-GalactosylCeramide (KRN7000)-Pulsed Dendritic Cells
Authors: Nicol Andrew J. , Tazbirkova Andrea , Nieda Mie
Published: April 2023

PDF file - 67K
Supplementary Figure 2 from Comparison of Clinical and Immunological Effects of Intravenous and Intradermal Administration of α-GalactosylCeramide (KRN7000)-Pulsed Dendritic Cells
Authors: Nicol Andrew J. , Tazbirkova Andrea , Nieda Mie
Published: April 2023

PDF file - 160K
Supplementary Figure 1 from Comparison of Clinical and Immunological Effects of Intravenous and Intradermal Administration of α-GalactosylCeramide (KRN7000)-Pulsed Dendritic Cells
Authors: Nicol Andrew J. , Tazbirkova Andrea , Nieda Mie
Published: April 2023

PDF file - 109K
CCR Translation for This Article from Phase II Efficacy and Pharmacogenomic Study of Selumetinib (AZD6244; ARRY-142886) in Iodine-131 Refractory Papillary Thyroid Carcinoma with or without Follicular Elements
Authors: Hayes D. Neil , Lucas Amy S. , Tanvetyanon Tawee , Krzyzanowska Monika K. , Chung Christine H. , Murphy Barbara A. , Gilbert Jill , Mehra Ranee , Moore Dominic T. , Sheikh Arif , Hoskins Janelle , Hayward Michele C. , Zhao Ni , O'Connor Wendi , Weck Karen E. , Cohen Roger B. , Cohen Ezra E.W.
Published: April 2023

CCR Translation for This Article from Phase II Efficacy and Pharmacogenomic Study of Selumetinib (AZD6244; ARRY-142886) in Iodine-131 Refractory Papillary Thyroid Carcinoma with or without Follicular Elements
Supplementary Figures 1-7, Methods from FGFR Signaling Promotes the Growth of Triple-Negative and Basal-Like Breast Cancer Cell Lines Both In Vitro and In Vivo
Authors: Sharpe Rachel , Pearson Alex , Herrera-Abreu Maria T. , Johnson Damian , Mackay Alan , Welti Jonathan C. , Natrajan Rachael , Reynolds Andrew R. , Reis-Filho Jorge S. , Ashworth Alan , Turner Nicholas C.
Published: April 2023

PDF file - 1.5MB
Supplementary Table 1 from Reovirus as a Viable Therapeutic Option for the Treatment of Multiple Myeloma
Authors: Thirukkumaran Chandini M. , Shi Zhong Qiao , Luider Joanne , Kopciuk Karen , Gao He , Bahlis Nizar , Neri Paola , Pho Mark , Stewart Douglas , Mansoor Adnan , Morris Don G.
Published: April 2023

PDF file, 21K, Reovirus sensitivity and prevalnet genetic lesions of myeloma cell lines used in the current study.
Supplementary Figure 4 from MARCKS Regulates Growth and Radiation Sensitivity and Is a Novel Prognostic Factor for Glioma
Authors: Jarboe John S. , Anderson Joshua C. , Duarte Christine W. , Mehta Tapan , Nowsheen Somaira , Hicks Patricia H. , Whitley Alexander C. , Rohrbach Timothy D. , McCubrey Raymond O. , Chiu Sherard , Burleson Tamara M. , Bonner James A. , Gillespie G. Yancey , Yang Eddy S. , Willey Christopher D.
Published: April 2023

PDF file, 102KB, Supplemental Figure S4 shows DAPI stained U251 control and knockdown cells after radiation.